DODI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 139
EU - Europa 122
AS - Asia 81
SA - Sud America 3
AF - Africa 2
Totale 347
Nazione #
US - Stati Uniti d'America 133
SG - Singapore 35
CN - Cina 34
IT - Italia 25
PL - Polonia 23
IE - Irlanda 15
SE - Svezia 15
RU - Federazione Russa 14
FR - Francia 12
DE - Germania 9
CA - Canada 6
CZ - Repubblica Ceca 3
HK - Hong Kong 3
ID - Indonesia 3
BE - Belgio 2
EC - Ecuador 2
JP - Giappone 2
TG - Togo 2
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
FI - Finlandia 1
IN - India 1
IR - Iran 1
KR - Corea 1
NL - Olanda 1
Totale 347
Città #
Chandler 38
Singapore 32
Dublin 15
Verona 13
Ashburn 12
Trento 6
Toronto 5
Ann Arbor 4
Lawrence 4
New York 4
Princeton 4
Seattle 4
Sindelfingen 4
Beijing 3
Boardman 3
Brno 3
Hong Kong 3
Jacksonville 3
Jakarta 3
Menlo Park 3
Redmond 3
Shenyang 3
Brussels 2
Guangzhou 2
Hangzhou 2
Houston 2
Huskvarna 2
Jinan 2
Lomé 2
Munich 2
Pieve Emanuele 2
Tianjin 2
Tokyo 2
Zhengzhou 2
Almere Stad 1
Andover 1
Baku 1
Chicago 1
Columbus 1
Dallas 1
Guayaquil 1
Hebei 1
Helsinki 1
Kent 1
Norwalk 1
Ottawa 1
Quito 1
Sacramento 1
Santa Clara 1
Seoul 1
Shanghai 1
Strasbourg 1
Taiyuan 1
Taizhou 1
Wilmington 1
Woodbridge 1
Zanjan 1
Zurich 1
Totale 220
Nome #
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 89
Integrating supportive care into the multidisciplinary management of lung cancer: we can't wait any longer 72
Infections and Immunotherapy in Lung Cancer: A Bad Relationship? 63
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned 53
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done 29
A qualitative study exploring the experiences and perspectives of patients with cancer attending a 12-week exercise program 17
Body composition as a modulator of response to immunotherapy in lung cancer: time to deal with it 17
Genetic and non-genetic resistance mechanisms in non-small cell lung cancer harboring (non-ALK) oncogenic fusions 11
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 8
Totale 359
Categoria #
all - tutte 1.966
article - articoli 1.966
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 0 0 4
2020/202121 2 3 1 2 0 2 0 8 1 0 2 0
2021/202265 1 7 0 2 3 2 0 2 2 1 11 34
2022/2023106 4 12 9 25 4 29 0 4 14 0 3 2
2023/202478 4 3 4 9 5 10 12 8 7 2 9 5
2024/202585 12 8 9 51 5 0 0 0 0 0 0 0
Totale 359